Abstract
Discovery of first-in-class mitogen activated protein kinase (MAPK) 8–10 activator for the treatment of high grade serous ovarian cancer (1287)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
